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Abstract
Objective: to develop and validate a prediction model for incident locomotor disability after 7 years in older adults.
Setting: prospective British cohort studies: British Women’s Heart and Health Study (BWHHS) for development and the
English Longitudinal Study of Ageing (ELSA) for validation.
Subjects: community-dwelling older adults.
Methods:multivariable logistic regression models after selection of predictors with backward elimination. Model performance
was assessed using metrics of discrimination and calibration. Models were internally and externally validated.
Results: locomotor disability was reported in BWHHS by 861 of 1,786 (48%) women after 7 years. Age, a history of arthritis
and low physical activity levels were the most important predictors of locomotor disability. Models using routine measures
as predictors had satisfactory calibration and discrimination (c-index 0.73). Addition of 31 blood markers did not increase
the predictive performance. External validation in ELSA showed reduced discrimination (c-index 0.65) and an underestimation
of disability risks. A web-based calculator for locomotor disability is available (http://www.sealedenvelope.com/trials/
bwhhsmodel/).
Conclusions: we developed and externally validated a prediction model for incident locomotor disability in older adults based
on routine measures available to general practitioners, patients and public health workers, and showed an adequate discrimin-
ation. Addition of blood markers from major biological pathways did not improve the performance of the model. Further
replication in additional data sets may lead to further enhancement of the current model.
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Introduction
Life expectancy has been increasing in recent decades, and
the proportion of people above 65 years has risen in the
United Kingdom (UK) from 5.3% in 1911 to 16.4% in 2011
[1]. Ageing is associated with multimorbidity [2], which often
results in disability and loss of independence, reduces quality
of life [3] and increases the risk of mortality [4]. Interventions
such as physical activity programs can have a positive effect
on disability in older adults [5, 6]. Nevertheless, rising
numbers of older disabled adults will increase demand on
the limited resources of health-care systems [7]. Accurate
identiﬁcation of older people at high risk of disability would
help to efﬁciently target preventive programs to these people,
help plan long-term care and treatments, and enable a more
efﬁcient design for randomised trials of interventions to
prevent the onset of disability [8].
Although a considerable amount of aetiological research
has been undertaken to identify risk factors for disability in
older adults [9–13], studies constructing prediction models
for incident disability in the general population are scarce.
Most studies used small to moderate samples or lacked exter-
nal validation [11, 13, 14]. Several studies found associations
between different biological pathways such as inﬂammation,
coagulation, liver or kidney disease as measured by serum
blood markers and disability [15–17], but it is unclear how
much these blood markers add to more readily available clin-
ical measures. To the best of our knowledge, no model to
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predict locomotor disability exists for community-dwelling
older adults in the general UK population.
We used data from two UK population-based prospective
studies to develop and validate a prediction model [18–20]
that can be used to predict incident locomotor disability
in older adults based on routine measures and tested the
potential beneﬁt of adding blood markers that proxy major
biological pathways associated with disability [17].
Materials and methods
The multivariable prediction models were developed in
the British Women’s Heart and Health Study (BWHHS),
and their performance was assessed by calibration and
discrimination [19, 20]. The English Longitudinal Study of
Ageing (ELSA) was used for external validation in another
population [18].
Development of the prediction model in BWHHS
Study sample
We used data from the BWHHS, a prospective cohort study
of women aged between 60 and 79 years who were randomly
selected from general practice lists in 23 towns in England,
Scotland and Wales [21]. Between 1999 and 2001, baseline
data were collected in 4,286 women using self-completed
questionnaires, interviews by a research nurse, physical exam-
inations and review of primary care medical records. In 2003
and 2007, follow-up data on outcomes using self-reported
questionnaires were collected.
Disability outcome
Participants were considered to suffer from locomotor dis-
ability if they reported difﬁculty with going up or down
stairs, bending down, straightening up, keeping balance,
going out of the house or walking 400 yards [17, 22].
Questions about locomotor disability were asked at baseline
and after 3 and 7 years. The primary outcome was locomotor
disability at 7 years and—as a secondary analysis—at 3 years.
Baseline variables
The selection of potential predictors was based on published
evidence of risk factors for our primary outcome and com-
prised age, health conditions, lifestyle factors, medication use
and available blood markers from major biological pathways
[13, 17, 22–24]. Details are provided in Supplementary data,
Appendix S1 available in Age and Ageing online. We included
31 blood markers that proxy the following pathways: inﬂam-
mation, coagulation, liver, renal and other metabolic disor-
ders. Blood markers were measured at baseline and details of
measurement procedures are reported elsewhere [17, 25, 26].
Statistical analysis
Women with locomotor disability at baseline were excluded
from all analyses. We used multivariable logistic regression
models accounting for the clustered sampling of women
within towns. Continuous variables were transformed using
natural logarithms as appropriate and entered as linear terms
in the regression models unless there was evidence for a
departure from linearity compared with quadratic or cubic
transformations using likelihood ratio tests. We explored
interactions between health conditions and medication use
and between blood pressure and use of cardiovascular medi-
cation. Missing data in candidate predictors were addressed
using multiple imputation with all candidate covariates in
the imputation model to create 10 imputations. We started
with all non-laboratory candidate predictors and performed
backward elimination to remove variables with P > 0.05
to obtain prediction models without blood markers. In a
second step, we examined whether addition of blood
markers improved the prediction of the previous models by
a backward elimination to remove blood markers with
P> 0.05. Calibration was examined by plotting observed
proportions against predicted risks and Hosmer–Lemeshow
P values. Discrimination was examined by receiver operation
characteristics (ROC) curves and concordance (c) index,
which is equivalent to the area under ROC curves. Internal
validation to assess optimism in model performance was
done using bootstrapping: we compared c-indices from
models developed in 200 bootstrap samples to c-indices in
the same models applied to the original sample [18, 20].
External validation of the prediction model in ELSA
We externally validated our models in the ELSA, a longitu-
dinal study from a representative sample of the English
population aged 50 and older [27]. Baseline data were col-
lected in 2002/03 from a total of 12,099 respondents using
self-completed questionnaires, face-to-face interviews and
clinical measurements. After 8 years, data on locomotor dis-
ability were obtained using self-completed questionnaires
[28]. We assessed calibration and discrimination of the model
constructed based on BWHHS data with the original coefﬁ-
cients in all ELSA data and in ELSA restricted to women
only. We also used ELSA to test whether gender is an inde-
pendent predictor of locomotor disability using a likelihood
ratio test. All P values are two sided.
Results
Development of the prediction model in BWHHS
Two thousand three hundred and seventy-seven women in
the BWHHS [17] reported no locomotor disability at base-
line and were included (Supplementary data, Appendix S2
available in Age and Ageing online). Women were on average
68 years old with a BMI of 26.9 kg/m2, 10% were current
smokers and 45% were physically active. The most frequent
health conditions were respiratory diseases (49%) and
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arthritis (37%). One thousand seven hundred and eighty-six
women were followed up after 7 years and 861 (48%)
reported locomotor disability. Variables contained a median
of 2% missing observations (range: 0–12%). Blood markers
used for model development are shown in Supplementary
data, Appendix S3 available in Age and Ageing online.
The strongest predictors (according to z-values) for loco-
motor disability after 7 years were age, low physical activity
and a history of arthritis (Table 1). In models without and
with blood markers predicted risks corresponded to
observed proportions (P = 0.47, Figure 1). Discrimination in
models without blood markers was satisfactory (c-index
0.73). Prediction models for locomotor disability after 3
years (Supplementary data, Appendix S4 available in Age and
Ageing online) or for a composite of locomotor disability and
death after 7 years were very similar (Supplementary data,
Appendix S5 available in Age and Ageing online). CRP and
IL-6 were the only blood markers of the 31 evaluated that
were retained, and when added to the prediction model, the
c-index increased to 0.74 (Table 1). Internal validation
showed only slight decreases of the c-index, indicating a very
low over-optimism in model development (Supplementary
data, Appendix S6 available in Age and Ageing online).
External validation in ELSA
Given the minimal increase in the prediction ability of adding
blood markers to the models, we only replicated the predic-
tion models without blood markers. In ELSA, 5,635
participants had no locomotor disability at baseline and of
these 3,194 (57%) with 8 years of follow-up were included.
Participants had a mean age of 61, 49% were women, 76%
were physically active, 14% had arthritis and only 7 (0.2%)
had a hip fracture (Supplementary data, Appendix S2 avail-
able in Age and Ageing online). Of these, 1,430 (45%) devel-
oped locomotor disability after 8 years. Figure 1 shows the
performance of the BWHHS prediction model in ELSA.
Discrimination was lower than in BWHHS (c-index 0.65),
and calibration suggested that predicted risks of locomotor
disability were lower than observed risks for all risk categor-
ies (P< 0.001). Discrimination and calibration were similar
when the model was applied to female ELSA participants
only (Supplementary data, Appendix S7 available in Age and
Ageing online). We also examined prediction models with and
without gender as additional predictor of locomotor disabil-
ity in ELSA (Supplementary data, Appendix S7 available in
Age and Ageing online). Although gender was an independent
predictor (P < 0.001), the c-index in the model with gender
as an additional predictor was comparable to the model with
original predictors as selected in BWHHS only (0.68 versus
0.67). Calibration was adequate in all models (P> 0.40).
Online calculator
Results were used to create an online calculator that pre-
dicts risks of locomotor disability available at http://www.
sealedenvelope.com/trials/bwhhsmodel/. Box 1 explains
details of calculation of predicted risks. While a ‘healthy’
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1.Multivariable prediction models for locomotor disability after 7 years (n= 1,786)
Predictors Model without blood markers Model with blood markers
OR 95% CI z score OR 95% CI z score
Age, per 10 years 2.40 (2.06–2.79) 11.29 2.36 (2.04–2.73) 11.60
Physical activity 0.56 (0.47–0.68) −5.99 0.61 (0.50–0.73) −5.07
Healthy diet 0.71 (0.51–0.97) −2.14 0.72 (0.51–1.01) −1.88
Smoker, former 1.46 (1.18–1.81) 3.53 1.46 (1.18–1.80) 3.46
Smoker, current 1.31 (0.84–2.05) 1.19 1.18 (0.78–1.78) 0.78
Systolic BP, per 10 mmHg 0.95 (0.91–0.99) −2.35 0.94 (0.90–0.98) −2.68
Medication use, per 1 drug 1.18 (1.11–1.26) 5.30 1.16 (1.09–1.23) 4.90
Arthritis 1.72 (1.44–2.06) 5.96 1.72 (1.42–2.08) 5.56
Depression 1.84 (1.41–2.39) 4.56 1.88 (1.45–2.42) 4.83
Cardiovascular disease 1.62 (1.18–2.22) 2.97 1.59 (1.16–2.20) 2.84
Hip fracture 1.84 (1.26–2.69) 3.15 1.77 (1.22–2.57) 2.99
CRP, per 1 ln(mg/l) 1.16 (1.01–1.32) 2.06
IL-6, per 1 ln(pg/ml) 1.60 (1.14–2.26) 2.71
IL-6, per 1 ln(pg/ml)2 0.92 (0.82–1.03) −1.45
Model performancea Median Range Median Range
c-Index 0.733 (0.732–0.733) 0.743 (0.742–0.747)
Hosmer–Lemeshow P value 0.466 (0.442–0.476) 0.474 (0.446–0.498)
95% CI, 95% confidence interval; BP, blood pressure; CRP, C-reactive protein; IL-6, interleukin-6; OR, odds ratio.
aMedian and ranges across 10 imputations.
Participants were considered physically active if they reported moderate to vigorous exercise for at least 2 h per week. Participants were considered to follow a healthy
diet if they reported to consume at least 4-5 portions of fruits or vegetables per day. Smoking was self-reported and classified as current, former or never smoker.
Alcohol consumption was self-reported and was classified into never, occasional (1-2 times a month or on special occasions only) and regular (daily on most days or
weekends only). Use of cardiovascular medication (aspirin, blood-pressure and lipid-lowering medication) was classified according to BNF codes. Self-reported
arthritis: osteoarthritis, rheumatoid arthritis or any other form. Cardiovascular disease: myocardial infarction, angina, stroke, claudication, deep vein thrombosis,
pulmonary embolism or aortic aneurysm. Hip fracture is self-reported by participants. Depression was considered present if participants reported being moderately or
extremely anxious or depressed on the respective question of the European Quality of Life (EQ-5D) instrument.
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woman reaches a risk of 39% locomotor disability by the age
of 80 (Example 1), a similar risk could already be present 20
years earlier with several risk factors present (Example 2).
Supplementary data, Appendix S8 available in Age and Ageing
online shows distributions of risk scores in women by loco-
motor disability status and corresponding predicted risks.
Locomotor disability risk at 7 years predicted from models
without blood markers ranged from 17% (95% CI 16–19%)
in women with the 10% lowest risk scores to 82% (95% CI
80–83%) in women with the 10% highest risk scores.
Accuracy of risk scores using the model without blood
markers (Supplementary data, Appendix S9 available in Age
and Ageing online) showed that higher risk score values (e.g.
70) are needed to get satisfactory power to rule in locomotor
disability, but at the expense of low sensitivity of 20%.
Discussion
Using data from two population-based prospective studies in
older British adults, we showed that a model containing
easily measured predictors, available to general practitioners
during routine medical evaluation, had a reasonable predic-
tion capacity and validity to identify incident disability.
We also provide an online calculator that could be implemen-
ted in primary care with minimal resources. The strongest
predictors in our model were older age, low physical activity
and a history of arthritis. Additional information on 31
blood markers covering major biological pathways had a
minimal incremental beneﬁt. The additional cost and logis-
tics associated with these blood markers therefore do not
justify their inclusion. Discrimination of the model in an
Figure 1. Performance of prediction models (without blood markers) for locomotor disability in the BWHHS after 7 years
(Development, Panel A) and in the ELSA after 8 years (External validation, Panel B), which was assessed by calibration using
expected and observed deciles of risks (left) and discrimination using ROC curves (right). Presented are median P values from
Hosmer–Lemeshow tests and median c-indices across 10 imputations.
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external sample was lower, which coincides with our internal
validation suggesting very low over-optimism. Calibration
suggested an underestimation of disability risks in the exter-
nal sample. However, good discriminatory capacity is more
important than good calibration, as the model aims at identi-
fying people with higher disability risks to prioritise allocation
of preventive care programs to those with the greatest need.
Strengths of our study include the wide range of potential
predictors available, the long follow-up of 7 years in the
BWHHS and the validation of our models in an external
sample. We found a reduced predictive capacity of our
models in ELSA, which might be due to differences in mea-
surements of some important predictors and in the preva-
lence of other characteristics such as alcohol consumption or
Box 1 Calculation of predicted risks of incident locomotor disability.
An online calculator to predict risks of locomotor disability is available from http://www.sealedenvelope.com/trials/
bwhhsmodel/.
Calculation of risks
The predicted risk πj of locomotor disability in the jth woman with k different risk factor levels xj is derived from logit
(πj) = β0 + Σi = 1 to k (βi*xij) with βi being the ith beta-coefﬁcient estimated from the prediction model.
5










respiratory conditions. The performance of these models
other populations in- and outside the United Kingdom
remains to be determined, and updating the model with
adjustments for baseline risks or predictor weights might
help to improve performance in external populations [18,
29]. Further strengths are relatively low missing data and the
use of imputation in baseline characteristics to further
improve this. However, one-fourth of the women without
baseline locomotor disability died or was lost to follow-up,
and was excluded, which might have resulted in an underesti-
mation of disability risks. Our prediction models were devel-
oped in women only, which may limit the application of our
models to men or mixed populations and may explain the
lower performance in the external mixed cohort. However,
when we assessed gender as additional predictive factor, the
increase in the discriminatory capacity was minimal. Some
variables reported to predict disability (e.g. cognitive function
and muscle strength) [11, 30] were not available in the
BWHHS and could have improved performance. However,
the wide range of predictors included means it is unlikely that
we have missed variables that would increase performance
substantially. For an unmeasured predictor to substantially
increase the prediction capacity, the variable would need not
only to be strongly associated with disability but also to be
minimally correlated with the predictors already included.
Women who died could not be assessed for locomotor
disability and were excluded from the main analyses, which
could have introduced selection bias. However, the perform-
ance of our model was similar for a composite of locomotor
disability or death. Accuracy of the derived risk scores was
limited, regardless of cut-offs chosen. Thus, rather extreme
cut-off values in the risk scores are needed to rule in or rule
out locomotor disability with sufﬁcient certainty for clinical
practice. However, it is important to note that the discrimin-
atory capacity of our model (c-index 0.71–0.74) is within the
range of values reported for the widely used Framingham risk
score used for risk prediction of coronary heart disease [31].
To our knowledge, this is the ﬁrst report to develop and
validate a prediction model for incident locomotor disability
[18–20]. All factors, which were retained in our prediction
model, have previously been reported to predict disability.
Variability of alcohol consumption in women in the BWHHS
is lower than in comparable studies [32]. This might explain
why we found low physical activity a stronger predictor, while
previous studies suggested alcohol use to be predictive [33].
Unlike other studies that included cases with (mild) disability
at baseline, we restricted our sample to participants free of
locomotor disability at baseline and were able to predict inci-
dent locomotor disability. Various cut-offs to denote different
levels of severity of disability have been used. Our prediction
models had a discrimination capacity similar to other predic-
tion models, but calibration and validation have not been
reported in other prediction models for disability [11, 33].
We developed a prediction model to identify older people
at high risk of developing incident locomotor disability,
because these people are likely to need more care when living
at home or even admission to residential care. Our prediction
model is intended to help target limited resources for
individual or community interventions to the most relevant
people. For example, interventions such as progressive resist-
ance training [5] require a substantial commitment from the
patient, the care giver and often physical resources (gym or
clinic). Further studies will be needed to determine whether
individuals at high risk of disability identiﬁed by our web-
based risk score beneﬁt from physical training, social or
other interventions, and whether use of health-care resources
are optimised. The risk score may also minimise resource
allocation to people at very low risk of developing disability.
Our prediction model is based on information that can
be obtained during a routine physician appointment or that
is available to people themselves without the need for a phys-
ician to administer it. However, before experimental studies
are conducted to evaluate its utility in primary care settings
and public health work, further replication of this model is
needed in additional samples that may serve to reﬁne the pre-
dictive capacity of the current model [18, 29]. To facilitate the
evaluation of the prediction model, we have implemented a
web-based calculator for locomotor disability risk (see http://
www.sealedenvelope.com/trials/bwhhsmodel).
Key points
• Prediction model for incident disability in older adults
based on routine measures was developed and validated.
• The model is available via a web-based calculator (http://
www.sealedenvelope.com/trials/bwhhsmodel/).
• Model showed adequate discriminatory ability and external
validity; addition of blood markers from major biological
pathways did not improve the performance.
Acknowledgements
We thank all participants of BWHHS and ELSA, the general
practitioners and their staff who have supported data collec-
tion. We are grateful to Sealed Envelope Ltd for the imple-




This work was supported by grants from the Department of
Health Policy Research Programme (England) (0090049)
and the British Heart Foundation (PG/09/022). EN was a
recipient of a Marie Curie Intra-European Fellowship for
Career Development (FP7-PEOPLE- 2010-IEF-273673).
PP is a member of the Medical Research Council Prognosis
6










Research Strategy (PROGRESS) Partnership (G0902393/
99558). The funders had no role in the study design; in the
collection, analysis and interpretation data; in the writing of the
report or in the decision to submit the paper for publication.
Ethical approval
Ethical approval was granted for the BWHHS from the
London Multi-Centre Research Ethics Committee and 23
Local Research Ethics Committees, and for all the ELSA
waves from the National Research and Ethics Committee.
All participants provided written informed consent.
Supplementary data
Supplementary data mentioned in the text are available to
subscribers in Age and Ageing online.
References
1. Census. Population Estimates for the United Kingdom. www.
ons.gov.uk: Ofﬁce of National Statistics 2011.
2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie
B. Epidemiology of multimorbidity and implications for health
care, research, and medical education: a cross-sectional study.
Lancet 2012; 380: 37–43.
3. Bowling A, Seetai S, Morris R, Ebrahim S. Quality of life
among older people with poor functioning. The inﬂuence of
perceived control over life. Age Ageing 2007; 36: 310–5.
4. Dale C, Prieto-Merino D, Kuper H et al. Modelling the associ-
ation of disability according to the WHO International
Classiﬁcation of Functioning, Disability and Health (ICF) with
mortality in the British Women’s Heart and Health Study. J
Epidemiol Community Health 2012; 66: 170–5.
5. Liu CJ, Latham NK. Progressive resistance strength training
for improving physical function in older adults. Cochrane
Database Syst Rev 2009; 3: CD002759.
6. Smith SM, Soubhi H, Fortin M, Hudon C, O’Dowd T.
Managing patients with multimorbidity: systematic review of
interventions in primary care and community settings. BMJ
2012; 345: e5205.
7. Pickard L. Informal Care for Older People Provided by Their
Adult Children: Projections of Supply and Demand to 2041
in England. www.pssru.ac.uk. London, UK: Personal Social
Services Research Unit 2008.
8. Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward
RA. Assessing and reporting heterogeneity in treatment effects
in clinical trials: a proposal. Trials 2010; 11: 85.
9. Buchman AS, Boyle PA, Leurgans SE, Evans DA, Bennett
DA. Pulmonary function, muscle strength, and incident mobil-
ity disability in elders. Proc Am Thorac Soc 2009; 6: 581–7.
10. Odding E, Valkenburg HA, Stam HJ, Hofman A. Determinants
of locomotor disability in people aged 55 years and over: the
Rotterdam Study. Eur J Epidemiol 2001; 17: 1033–41.
11. Tas U, Steyerberg EW, Bierma-Zeinstra SM, Hofman A, Koes
BWVerhagen AP. Age, gender and disability predict future dis-
ability in older people: the Rotterdam Study. BMC Geriatr
2011; 11: 22.
12. Tas U, Verhagen AP, Bierma-Zeinstra SM et al. Incidence and
risk factors of disability in the elderly: the Rotterdam Study.
Prev Med 2007; 44: 272–8.
13. Tas U, Verhagen AP, Bierma-Zeinstra SM, Odding E, Koes
BW. Prognostic factors of disability in older people: a systemat-
ic review. Br J Gen Pract 2007; 57: 319–23.
14. den Ouden ME, Schuurmans MJ, Mueller-Schotte S, van der
Schouw YT. Identiﬁcation of high-risk individuals for the de-
velopment of disability in activities of daily living. A ten-year
follow-up study. Exp Gerontol 2013; 48: 437–43.
15. Cook WL. The intersection of geriatrics and chronic kidney
disease: frailty and disability among older adults with kidney
disease. Adv Chronic Kidney Dis 2009; 16: 420–9.
16. Claessen H, Brenner H, Drath C, Arndt V. Gamma-glutamyl-
transferase and disability pension: a cohort study of construc-
tion workers in Germany. Hepatology 2010; 51: 482–90.
17. Nuesch E, Dale CE, Amuzu A et al. Inﬂammation, coagulation
and risk of locomotor disability in elderly women: ﬁndings
from the British Women’s Heart and Health Study. Eur J
Epidemiol 2012; 27: 633–45.
18. Altman DG, Vergouwe Y, Royston P, Moons KG. Prognosis
and prognostic research: validating a prognostic model. BMJ
2009; 338: b605.
19. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman
DG. Prognosis and prognostic research: what, why, and how?
BMJ 2009; 338: b375.
20. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis
and prognostic research: developing a prognostic model. BMJ
2009; 338: b604.
21. Lawlor DA, Bedford C, Taylor M, Ebrahim S. Geographical
variation in cardiovascular disease, risk factors, and their
control in older women: British Women’s Heart and Health
Study. J Epidemiol Community Health 2003; 57: 134–40.
22. Ebrahim S, Wannamethee SG, Whincup P, Walker M, Shaper
AG. Locomotor disability in a cohort of British men: the
impact of lifestyle and disease. Int J Epidemiol 2000; 29:
478–86.
23. Wannamethee SG, Ebrahim S, Papacosta O, Shaper AG. From
a postal questionnaire of older men, healthy lifestyle factors
reduced the onset of and may have increased recovery from
mobility limitation. J Clin Epidemiol 2005; 58: 831–40.
24. Ebrahim S, Adamson J, Ayis S, Beswick A, Gooberman-Hill
R. Locomotor disability: meaning, causes and effects of inter-
ventions. J Health Serv Res Policy 2008; 13(Suppl. 3): 38–46.
25. Gaunt TR, Lowe GDO, Lawlor DA, Casas JP, Day INM. A
gene-centric analysis of activated partial thromboplastin time
and activated protein C resistance using the Human CVD
focused genotyping array. Eur J Hum Genet 2013; 21: 779–83.
26. Jefferis BJ, Lowe GD, Welsh P et al. Secondhand smoke (SHS)
exposure is associated with circulating markers of inﬂamma-
tion and endothelial function in adult men and women.
Atherosclerosis 2010; 208: 550–6.
27. Marmot M, Banks J, Blundell R, Lessof C, Nayroo J, eds.
Health, Wealth and Lifestyle of the Older Population in
England: The 2002 English Longitudinal Study of Ageing.
London: Institute for Fiscal Studies, 2002.
28. Angleman SB, Harris TB, Melzer D. The role of waist circum-
ference in predicting disability in periretirement age adults. Int
J Obes (Lond) 2006; 30: 364–73.
29. Moons KG, Altman DG, Vergouwe Y, Royston P. Prognosis
and prognostic research: application and impact of prognostic
models in clinical practice. BMJ 2009; 338: b606.
7










30. Rajan KB, Hebert LE, Scherr PA, Mendes de Leon CF, Evans
DA. Disability in basic and instrumental activities of daily living
is associated with faster rate of decline in cognitive function of
older adults. J Gerontol A Biol Sci Med Sci 2013; 68: 624–30.
31. Tzoulaki I, Liberopoulos G, Ioannidis JP. Assessment of
claims of improved prediction beyond the Framingham risk
score. JAMA 2009; 302: 2345–52.
32. Ebrahim S, Lawlor DA, Shlomo YB et al. Alcohol dehydro-
genase type 1C (ADH1C) variants, alcohol consumption
traits, HDL-cholesterol and risk of coronary heart disease
in women and men: British Women’s Heart and Health
Study and Caerphilly cohorts. Atherosclerosis 2008; 196:
871–8.
33. Tas U, Verhagen AP, Bierma-Zeinstra SM, Hofman A, Pols
HAKoes BW. Course and prognostic factors of disability in
community-dwelling older people with mild disability: the
Rotterdam Study. Australas J Ageing 2012; 31: 28–33.
Received 24 March 2014; accepted in revised form
29 August 2014
8
E. Nüesch et al.
 at U
niversity of Southam
pton on O
ctober 29, 2014
http://ageing.oxfordjournals.org/
D
ow
nloaded from
 
